BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 1703192)

  • 1. Modulation of Bordetella pertussis infection with monoclonal antibodies to pertussis toxin.
    Halperin SA; Issekutz TB; Kasina A
    J Infect Dis; 1991 Feb; 163(2):355-61. PubMed ID: 1703192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epitope specificity of three anti-pertussis toxin monoclonal antibodies with dissimilar effects in assays of toxin neutralizing activity.
    Halperin SA; Issekutz TB; Kasina A
    Mol Immunol; 1991 Mar; 28(3):247-50. PubMed ID: 1708105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective activities in mice of monoclonal antibodies against pertussis toxin.
    Sato H; Sato Y
    Infect Immun; 1990 Oct; 58(10):3369-74. PubMed ID: 1698179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between structure and biological and protective activities of pertussis toxin.
    Sato H; Sato Y
    Dev Biol Stand; 1991; 73():121-32. PubMed ID: 1723387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of pertussis toxin B oligomer-mediated protection against Bordetella pertussis respiratory infection.
    Shahin RD; Witvliet MH; Manclark CR
    Infect Immun; 1990 Dec; 58(12):4063-8. PubMed ID: 2254030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural relationship between the S1 and S4 subunits of pertussis toxin.
    Sato H; Sato Y
    FEMS Microbiol Lett; 1994 Jan; 115(1):63-9. PubMed ID: 7510256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibody against pertussis toxin: effect on toxin activity and pertussis infections.
    Sato H; Ito A; Chiba J; Sato Y
    Infect Immun; 1984 Nov; 46(2):422-8. PubMed ID: 6094351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of antibodies elicited by immunization with pertussis toxin.
    Kaslow HR; Schlotterbeck JD; Gotto J
    Dev Biol Stand; 1991; 73():143-50. PubMed ID: 1778308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chick embryo, a model to study the lethal activity of pertussis toxin, infectivity of Bordetella pertussis, and their neutralization by immune sera.
    Calver GA; Burton WW; Gardell CY
    Can J Microbiol; 1993 Aug; 39(8):759-66. PubMed ID: 8106134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of monoclonal antibody to pertussis toxin on toxin activity.
    Sato H; Sato Y; Ito A; Ohishi I
    Infect Immun; 1987 Apr; 55(4):909-15. PubMed ID: 2435660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective immunogenicity of synthetic peptides selected from the amino acid sequence of Bordetella pertussis toxin subunit S1.
    Askelöf P; Rodmalm K; Wrangsell G; Larsson U; Svenson SB; Cowell JL; Undén A; Bartfai T
    Dev Biol Stand; 1991; 73():111-20. PubMed ID: 1778305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of mutant strains producing pertussis toxin cross reacting materials.
    Sato Y; Sato H; Chazono M; Ginnaga A; Tamura C
    Dev Biol Stand; 1991; 73():93-107. PubMed ID: 1778339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of pertussis toxin (PT)-neutralizing activities and mouse-protective activities of anti-PT mouse monoclonal antibodies.
    Sato H; Sato Y; Ohishi I
    Infect Immun; 1991 Oct; 59(10):3832-5. PubMed ID: 1894382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies against pertussis toxin. Biochemical characterization and biological activity.
    Au-Jensen M; Schou C; Heron I
    Ann Sclavo Collana Monogr; 1986; 3(1-2):269-76. PubMed ID: 2447922
    [No Abstract]   [Full Text] [Related]  

  • 15. Neutralizing antibodies and immunoprotection against pertussis and tetanus obtained by use of a recombinant pertussis toxin-tetanus toxin fusion protein.
    Boucher P; Sato H; Sato Y; Locht C
    Infect Immun; 1994 Feb; 62(2):449-56. PubMed ID: 7507893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reciprocal protective immunity against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection.
    Watanabe M; Nagai M
    Infect Immun; 2001 Nov; 69(11):6981-6. PubMed ID: 11598073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibody that neutralizes pertussis toxin activities.
    Pootong A; Budhirakkul P; Tongtawe P; Tapchaisri P; Chongsa-nguan M; Chaicumpa W
    Asian Pac J Allergy Immunol; 2007 Mar; 25(1):37-45. PubMed ID: 17891920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and immunological characterization of HPLC-purified pertussis toxin subunits.
    Chong P; Cockle S; Boux H; Klein M
    Biochem Cell Biol; 1991; 69(5-6):336-40. PubMed ID: 1654940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibody against pertussis toxin: relationship between toxin neutralization and mouse protection activities.
    Sato H; Sato Y; Ito A
    Ann Sclavo Collana Monogr; 1986; 3(1-2):259-67. PubMed ID: 2962594
    [No Abstract]   [Full Text] [Related]  

  • 20. Crucial role of antibodies to pertactin in Bordetella pertussis immunity.
    Hellwig SM; Rodriguez ME; Berbers GA; van de Winkel JG; Mooi FR
    J Infect Dis; 2003 Sep; 188(5):738-42. PubMed ID: 12934190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.